TP53 and cancer: Our results also suggest that a similar approach could be used in those types of cancer which have been shown to have increased oxidation levels or similar mechanisms of transformation as TNBC (e.g., BRCA1 inactivation, RB1 loss, TP53 inactivation or amplifications in the MAPK pathway) (7).